Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · IEX Real-Time Price · USD
22.05
+0.19 (0.87%)
May 3, 2024, 4:00 PM EDT - Market closed

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017201620152014
Market Capitalization
1,8731,5051,5331,081909238111214130--
Market Cap Growth
--1.81%41.76%18.95%281.43%115.61%-48.27%63.79%---
Enterprise Value
1,2979291,049655636179308425-872
PE Ratio
-7.19-7.19-10.2643.38-11.79-4.25-1.49-3.51-2.77--
PS Ratio
---7.74599.16157.0872.85101.36106.92--
PB Ratio
3.382.723.282.653.607.542.082.051.55--
P/FCF Ratio
-9.37-9.37-11.4937.28-12.76-4.71-1.61-4.50-3.68--
P/OCF Ratio
-9.37-9.37-11.4737.11-12.76-4.71-1.61-4.51-3.71--
EV/Sales Ratio
---4.69419.44118.2719.4539.6520.46-138.03-
EV/EBITDA Ratio
-4.46-4.46-7.2024.02-8.58-3.23-0.40-1.34-0.520.85-0.06
EV/EBIT Ratio
-4.44-4.44-7.1824.43-8.52-3.20-0.40-1.34-0.520.84-0.06
EV/FCF Ratio
-5.78-5.78-7.8622.59-8.93-3.54-0.43-1.76-0.7034.94-0.11
Debt / Equity Ratio
0.000.000.000.050.080.03-----0.09
Debt / EBITDA Ratio
-0.01-0.01-0.010.77-0.28-0.02-----0.53
Debt / FCF Ratio
-0.01-0.01-0.010.72-0.29-0.02-----0.96
Quick Ratio
9.959.9516.7921.6115.543.255.038.2310.1817.851.18
Current Ratio
10.0010.0016.8521.6815.843.395.188.4510.4718.161.20
Asset Turnover
0000.450.010.020.020.020.010.01-
Interest Coverage
-1005.54-1005.54-46.6114.13-31.70-----72.44-90.20
Return on Equity (ROE)
-47.90%-47.90%-38.70%9.50%-52.70%-112.40%-107.70%-63.50%-47.30%51.30%-
Return on Assets (ROA)
-44.00%-44.00%-35.40%8.10%-39.60%-68.60%-72.90%-49.20%-38.40%-202.20%-
Return on Capital (ROIC)
-41.37%-41.37%-32.38%6.11%-26.19%-177.06%-143.04%-59.39%-52.02%8.13%15.38%
Earnings Yield
-11.17%-13.91%-9.74%2.31%-8.48%-23.52%-66.92%-28.46%-36.08%--
FCF Yield
-8.57%-10.67%-8.71%2.68%-7.84%-21.24%-62.18%-22.21%-27.15%--
Buyback Yield / Dilution
-15.82%-15.82%-13.31%-29.81%-35.48%-20.18%-20.83%-43.62%-21288.86%-17.48%-
Total Shareholder Return
-15.82%-15.82%-13.31%-29.81%-35.48%-20.18%-20.83%-43.62%-21288.86%-17.48%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).